Drug sensitivity assay for leukaemic cells by flow cytometry

Area of Science:

• Hematology
• Oncology
• Biotechnology

Background:

• Drug sensitivity assays are crucial in oncology for predicting patient response to anti-cancer therapies.
• Current methods for assessing drug sensitivity in leukemia are often time-consuming and labor-intensive.
• A simplified assay is needed to efficiently evaluate the in vitro drug sensitivity of leukaemic cells.

Purpose of the Study:

• To develop and validate a simplified flow cytometry-based assay for evaluating the in vitro drug sensitivity of leukaemic cells.
• To compare the efficacy and efficiency of the novel flow cytometry assay with the established MTT assay.

Main Methods:

• Investigated chemo-sensitivity of three human leukaemic cell lines (Jurkat, K 562, HL-60) using flow cytometry.
• Determined LD50 (50% inhibitory concentration) for prednisolone and daunorubicin.
• Assessed percent cell death via propidium iodide staining and flow cytometry, comparing results with the MTT assay.

Main Results:

• The flow cytometry assay demonstrated dose-dependent cytotoxic effects for the tested drugs.
• LD50 values obtained by flow cytometry were comparable to those from the MTT assay for prednisolone and daunorubicin.
• Inter-assay variation for the flow cytometry assay was found to be low (6-14%).

Conclusions:

• A rapid, technically simple, and reproducible flow cytometry-based drug-sensitivity assay for leukaemic cells has been developed.
• This assay offers a viable alternative to the labor-intensive MTT assay, with comparable results.
• The assay is suitable for suspension cells but not for adherent cell lines.